Pegylated Liposomal Doxorubicin, Low Freq Dexamethasone & Revlimid (Dd-R) in Newly Diagnosed Multiple Myeloma (MM)
Clinical trial NCT00617591 · COMPLETED
Trial details
- NCT number
- NCT00617591
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2013-04-01
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.